The best way to lose man boobs depends on understanding what is actually causing them. Enlarged male breast tissue — known medically as gynaecomastia — affects men of all ages and can result from hormonal imbalance, excess body fat, medications, or underlying health conditions. Some cases resolve with lifestyle changes, whilst others require medical or surgical intervention. This article explains the difference between true gynaecomastia and chest fat, outlines evidence-based approaches to treatment, and clarifies when to seek advice from a GP — helping you make informed decisions about your health.

What Causes Enlarged Breast Tissue in Men?

Gynaecomastia is caused by a relative excess of oestrogen over testosterone and can result from puberty, ageing, obesity, medications, or underlying conditions such as hypogonadism or testicular tumours.

Enlarged breast tissue in men is a common and often distressing condition that can affect males at any age, from newborns to older adults. The medical term for this is gynaecomastia, which refers specifically to the benign proliferation of glandular breast tissue in males. It is a recognised clinical condition with identifiable causes, not simply a cosmetic concern.

The primary driver of gynaecomastia is a hormonal imbalance — specifically, an altered ratio of oestrogen to testosterone. When oestrogen levels are relatively elevated compared to androgens, breast glandular tissue can develop. This imbalance can arise from a number of causes, including:

• Puberty — a very common and usually temporary cause in adolescent boys; pubertal gynaecomastia typically resolves spontaneously within 6–24 months without treatment

• Ageing — testosterone levels naturally decline with age, shifting the hormonal balance

• Obesity — excess body fat increases the peripheral conversion of androgens to oestrogens

• Medications — including spironolactone, digoxin, cimetidine, bicalutamide, finasteride, dutasteride, GnRH analogues, some antipsychotics, anabolic steroids, and certain antiretrovirals (e.g., efavirenz)

• Underlying health conditions — such as hypogonadism, Klinefelter syndrome, hyperthyroidism, liver cirrhosis, renal failure, or testicular tumours (which may secrete hCG and drive oestrogen production)

• Recreational drug use — anabolic steroids and alcohol are well-documented contributors; cannabis has been associated with gynaecomastia in some reports, though the evidence remains limited and inconclusive

In many cases, particularly during puberty, gynaecomastia resolves on its own. However, when it persists or causes significant discomfort, further investigation is warranted. It is also important to note that a firm, unilateral lump beneath the nipple — particularly in older men — may require prompt assessment to exclude male breast cancer, which, whilst uncommon, does occur.

Sources: NICE CKS: Gynaecomastia; NHS UK: Gynaecomastia; BMJ Best Practice: Gynaecomastia

Gynaecomastia vs Chest Fat: Understanding the Difference

True gynaecomastia involves firm glandular tissue beneath the nipple that does not respond to diet and exercise, whereas pseudogynaecomastia is soft chest fat that can reduce with overall weight loss.

One of the most important distinctions when addressing enlarged male breasts is whether the tissue is true gynaecomastia (glandular breast tissue) or pseudogynaecomastia (excess fatty tissue deposited in the chest area). The two conditions look similar but have different causes and respond to different interventions.

True gynaecomastia involves the growth of actual glandular breast tissue beneath the nipple-areola complex. On self-examination, this typically feels like a firm or rubbery disc of tissue directly under the nipple. It may be tender or sensitive to touch, particularly in the early stages. This type does not respond to diet and exercise alone, because the tissue itself is glandular rather than adipose.

Pseudogynaecomastia, by contrast, is caused by the accumulation of fatty tissue across the chest, often associated with general weight gain or obesity. It tends to feel softer and is more evenly distributed across the chest rather than concentrated beneath the nipple. Importantly, this type can respond well to lifestyle changes such as improved diet and regular exercise, as reducing overall body fat will reduce chest fat proportionally.

In practice, many men have a combination of both glandular and fatty tissue, which can complicate assessment. A GP can help differentiate between the two through clinical examination and, where necessary, referral to a symptomatic breast clinic, where specialists can arrange appropriate imaging such as breast ultrasound or mammography. Understanding which type you have is essential before deciding on the most appropriate course of action, as the management pathways differ considerably.

If you notice a hard, irregular, or one-sided lump — particularly with skin or nipple changes — you should seek prompt medical advice. Under NICE guideline NG12, men aged 50 and over with a unilateral, firm subareolar mass (with or without skin or nipple changes) should be referred urgently to be seen within two weeks to exclude breast cancer. Attempting to 'exercise away' true gynaecomastia without medical input is unlikely to be effective and may delay appropriate treatment.

Sources: NICE NG12: Suspected cancer — recognition and referral; NICE CKS: Gynaecomastia; Association of Breast Surgery guidance on symptomatic breast disease

Lifestyle Changes That Can Help Reduce Chest Size

Lifestyle changes — including a calorie-controlled diet and at least 150 minutes of moderate-intensity exercise per week — are most effective for pseudogynaecomastia but are unlikely to resolve true glandular gynaecomastia.

For men whose enlarged chest is primarily due to excess body fat (pseudogynaecomastia), or who have a mixed picture, targeted lifestyle changes can make a meaningful difference. Whilst there is no single 'best way to lose man boobs' that works for everyone, a consistent, evidence-based approach to overall fat reduction is the most effective strategy.

Dietary changes are central to reducing body fat. A calorie-controlled diet that prioritises whole foods — lean proteins, vegetables, wholegrains, and healthy fats — whilst limiting ultra-processed foods, refined sugars, and excess alcohol, supports sustainable weight loss. Alcohol is worth particular attention: UK Chief Medical Officers advise keeping consumption to no more than 14 units per week, spread across several days, and avoiding binge drinking. Alcohol contributes both to caloric excess and to hormonal disruption that may worsen gynaecomastia. It is also worth noting that weight loss in men with obesity can help restore testosterone levels, which may further support improvement.

Regular physical activity plays a complementary role. Whilst spot reduction of fat in a specific area is not physiologically possible, reducing overall body fat through a combination of:

• Cardiovascular exercise (e.g., brisk walking, cycling, swimming) — at least 150 minutes of moderate-intensity activity per week, in line with UK Chief Medical Officers' guidelines

• Muscle-strengthening activities — on at least two days per week, targeting major muscle groups including the chest and upper body

...can lead to visible improvements over time and supports overall metabolic health.

Reducing anabolic steroid use or recreational drug use is also strongly advised, as these are known contributors to hormonal imbalance. If a prescribed medication is suspected as a cause, this should be discussed with a GP before making any changes — never stop a prescribed medicine without medical advice.

Lifestyle changes are most effective for pseudogynaecomastia; for true glandular gynaecomastia, they are supportive but unlikely to resolve the condition entirely.

Sources: UK Chief Medical Officers' Physical Activity Guidelines (NHS summary); NHS alcohol guidelines (UK CMO low-risk drinking guidance)

When to See a GP About Gynaecomastia

You should see a GP if breast enlargement persists, is painful, involves a hard or one-sided lump, or causes significant distress; men aged 50 and over with a unilateral firm lump require urgent two-week referral under NICE NG12.

Many men feel embarrassed to seek medical advice about enlarged breast tissue, but gynaecomastia is a common and well-recognised condition that GPs are experienced in assessing. Early consultation is particularly important in certain circumstances.

You should make an appointment with your GP if:

• Breast tissue enlargement persists beyond a few months in adults (or does not resolve within the expected timeframe in adolescents)

• There is pain, tenderness, or sensitivity in the breast tissue

• You notice a hard, irregular, or one-sided lump — particularly one not centred beneath the nipple, or accompanied by skin changes, nipple changes, or swollen lymph nodes in the armpit

• There is any nipple discharge, especially if bloodstained

• The condition is causing significant psychological distress or affecting your quality of life

• You suspect a medication you are taking may be contributing

• You have other symptoms suggesting an underlying hormonal or systemic condition, such as fatigue, changes in libido, or unexplained weight changes

Urgent referral: Under NICE guideline NG12, men aged 50 and over with a unilateral, firm subareolar mass (with or without skin or nipple changes) should be referred urgently to be seen within two weeks to exclude breast cancer. If your GP suspects a testicular tumour as a cause, they will arrange a testicular examination and may request serum hCG (human chorionic gonadotrophin), with urgent urology referral if a testicular mass is identified.

At your appointment, your GP will take a full medical and medication history, perform a clinical examination, and may arrange blood tests to assess hormone levels — including testosterone, LH, FSH, oestradiol, prolactin, hCG, and thyroid function — as well as liver and kidney function. Where there is diagnostic uncertainty or concern about breast pathology, your GP will refer you to a symptomatic breast clinic, where specialists can arrange appropriate imaging such as breast ultrasound or mammography.

NICE CKS guidance on gynaecomastia supports investigation and onward referral where an underlying cause is suspected or where the condition is causing significant distress. Do not delay seeking advice — early assessment leads to better outcomes.

Sources: NICE NG12: Suspected cancer — recognition and referral; NICE CKS: Gynaecomastia; NHS UK: Gynaecomastia

Medical and Surgical Treatment Options Available on the NHS

No medicine is licensed in the UK for gynaecomastia, but specialists may use tamoxifen or raloxifene off-label; surgery (subcutaneous mastectomy or liposuction) is the most definitive treatment, subject to NHS ICB commissioning criteria.

Where gynaecomastia has an identifiable underlying cause — such as a hormonal disorder, medication side effect, or systemic illness — treating that cause is the first-line approach and may lead to gradual resolution of the breast tissue. For example, switching or stopping an offending medication (under medical supervision) can result in improvement over time.

Pharmacological treatment: There is currently no medicine licensed in the UK specifically for gynaecomastia. However, in selected cases — particularly where the condition is recent in onset (typically within the first 6–12 months, when tissue is still in the proliferative phase) and causing significant symptoms — specialists may consider off-label use of:

• Tamoxifen (a selective oestrogen receptor modulator, or SERM) — may reduce breast tissue volume and tenderness when used off-label

• Raloxifene — another SERM occasionally used in specialist settings

These medicines are initiated by an endocrinologist or specialist rather than in primary care, following individual clinical assessment and shared decision-making. Both carry potential risks, including a small increase in thromboembolic (blood clot) risk, and their use requires careful consideration of each patient's circumstances. If you experience any suspected side effects from a medicine, you can report these via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk).

For further prescribing information, refer to the BNF entries for tamoxifen and raloxifene, and the relevant emc (MHRA) Summary of Product Characteristics.

Surgical treatment is the most definitive option for established gynaecomastia, particularly where glandular tissue has been present for a prolonged period and is unlikely to resolve spontaneously. The main surgical approaches include:

• Subcutaneous mastectomy — removal of glandular breast tissue through a small incision

• Liposuction — used where there is a significant fatty component

• A combination of both techniques

NHS funding for gynaecomastia surgery is subject to local Integrated Care Board (ICB) commissioning policies and the NHS Evidence-Based Interventions programme; it is generally considered where the condition causes significant functional impairment or psychological distress meeting local criteria. Private surgical options are also available for those who do not meet NHS criteria. A GP referral to an appropriate specialist service is the correct starting point for exploring surgical options.

Sources: BNF: Tamoxifen; Raloxifene; emc (MHRA) SmPC: Tamoxifen; Raloxifene; NICE CKS: Gynaecomastia; NHS Evidence-Based Interventions programme

Supporting Your Mental Health and Body Confidence

Gynaecomastia is associated with anxiety, depression, and low self-esteem; NHS Talking Therapies offers CBT and counselling, and men experiencing disproportionate distress should be assessed for body dysmorphic disorder.

The psychological impact of gynaecomastia is frequently underestimated. Research consistently shows that men with enlarged breast tissue experience higher rates of anxiety, depression, low self-esteem, and social withdrawal compared to the general population. Feelings of embarrassment, shame, or self-consciousness — particularly around activities such as swimming, exercise, or intimacy — are very common and entirely understandable.

It is important to acknowledge that these emotional responses are valid and deserve attention alongside any physical treatment. If you are struggling with your mental health in relation to your body image, there are several avenues of support:

• Talking to your GP — they can refer you to psychological support services, including NHS Talking Therapies (formerly IAPT), which offers cognitive behavioural therapy (CBT) and counselling for anxiety and depression. You can also self-refer via the NHS Talking Therapies website

• Peer support — connecting with others who have had similar experiences, through reputable online communities or patient groups, can reduce feelings of isolation

• Body dysmorphic disorder (BDD) — in some cases, distress about physical appearance may be disproportionate to the actual degree of change. If intrusive thoughts about your appearance are significantly affecting daily functioning, it is important to discuss this with a GP or mental health professional. BDD requires specific therapeutic input, and NICE guideline CG31 (OCD and BDD) provides guidance on its assessment and treatment

It is also worth remembering that gynaecomastia is extremely common — studies suggest it affects a substantial proportion of adolescent boys and adult men across all age groups. You are far from alone. Addressing both the physical and emotional dimensions of this condition leads to the best overall outcomes, and seeking help — whether from a GP, a surgeon, or a therapist — is a sign of strength, not weakness.

Sources: NHS Talking Therapies; NICE guideline CG31: Obsessive-compulsive disorder and body dysmorphic disorder; BMJ Best Practice: Gynaecomastia

Frequently Asked Questions